The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent.
Saved in:
| Title: | The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. |
|---|---|
| Authors: | Stringer F; Takeda Pharmaceutical Company, 1-1, Doshomachi 4-Chome, Chuo-Ku, Osaka 540-8645, Japan. fran.stringer@takeda.com, Scott G, Valbuena M, Kinley J, Nishihara M, Urquhart R |
| Source: | European journal of clinical pharmacology [Eur J Clin Pharmacol] 2013 Mar; Vol. 69 (3), pp. 423-30. Date of Electronic Publication: 2012 Sep 09. |
| Publication Type: | Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 22960998 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stringer+F%22">Stringer F</searchLink>; Takeda Pharmaceutical Company, 1-1, Doshomachi 4-Chome, Chuo-Ku, Osaka 540-8645, Japan. fran.stringer@takeda.com<br /><searchLink fieldCode="AU" term="%22Scott+G%22">Scott G</searchLink><br /><searchLink fieldCode="AU" term="%22Valbuena+M%22">Valbuena M</searchLink><br /><searchLink fieldCode="AU" term="%22Kinley+J%22">Kinley J</searchLink><br /><searchLink fieldCode="AU" term="%22Nishihara+M%22">Nishihara M</searchLink><br /><searchLink fieldCode="AU" term="%22Urquhart+R%22">Urquhart R</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%221256165%22">European journal of clinical pharmacology</searchLink> [Eur J Clin Pharmacol] 2013 Mar; Vol. 69 (3), pp. 423-30. <i>Date of Electronic Publication: </i>2012 Sep 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>1256165 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200316970%22">00316970 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Clin Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22960998 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00228-012-1382-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 423 Titles: – TitleFull: The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stringer F – PersonEntity: Name: NameFull: Scott G – PersonEntity: Name: NameFull: Valbuena M – PersonEntity: Name: NameFull: Kinley J – PersonEntity: Name: NameFull: Nishihara M – PersonEntity: Name: NameFull: Urquhart R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2013 Mar Type: published Y: 2013 Identifiers: – Type: issn-electronic Value: 1432-1041 Numbering: – Type: volume Value: 69 – Type: issue Value: 3 Titles: – TitleFull: European journal of clinical pharmacology Type: main |
| ResultId | 1 |
